Acinetobacter baumannii infection in intensive care unit: analysis of distribution and drug resistance

Siyang Zhao1, Bing Zhang2, Conghai Liu2

  • 1Department of Clinical Research Center, Dazhou Central Hospital, Dazhou, Sichuan province, China.

Molecular Biology Reports
|January 16, 2024
PubMed
Abstract

Insights

Acinetobacter baumannii infections in intensive care units (ICUs) show increasing isolation and drug resistance, particularly multi-drug resistance. All imipenem-resistant strains carried the OXA-23 gene, highlighting the need for enhanced infection control.

Area of Science:

  • Medical Microbiology
  • Infectious Diseases
  • Intensive Care Medicine

Background:

  • Acinetobacter baumannii (A. baumannii) infections are a growing concern in intensive care units (ICUs), leading to increased morbidity and mortality.
  • Rising isolation and drug resistance rates necessitate analysis of A. baumannii characteristics in ICUs.

Purpose of the Study:

  • To analyze the distribution, drug resistance, and influencing factors of A. baumannii in ICU patients.
  • To provide data for effective infection prevention and clinical treatment strategies.

Main Methods:

  • Retrospective analysis of A. baumannii infected patients in the ICU from January 2020 to December 2021.
  • Bacterial culture, drug sensitivity testing, and drug-resistant gene detection (OXA-23) were performed on isolated strains.

Main Results:

  • A total of 197 A. baumannii strains were isolated in 2021, an increase from 2020. Specimens were primarily from lower respiratory tract secretions.
  • Multi-drug resistance in A. baumannii isolates remains high, with significant increases in resistance to tobramycin, gentamicin, and trimethoprim-sulfamethoxazole in 2021 compared to 2020.
  • All imipenem-resistant A. baumannii strains harbored the OXA-23 gene.

Conclusions:

  • Clinical antibiotic use should be guided by bacterial resistance patterns.
  • Strengthening hospital infection prevention and control measures, including disinfection and isolation, is crucial to reduce cross-infection risks.

Related Concept Videos

Estimation of k and VD of Aminoglycosides01:20

Estimation of k and VD of Aminoglycosides

Aminoglycosides are a class of antibiotics used to treat various bacterial infections. Clinicians must determine the elimination rate constant (k) and volume of distribution (VD) to optimize therapeutic efficacy and minimize toxicity. The k value represents the rate at which the drug is removed from the body, and the VD reflects the degree to which the drug distributes into body tissues. Accurately estimating these parameters allows healthcare professionals to tailor drug dosing to individual...
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...